Drug Trial Radar · NCT00413218
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Last checked: Nov 20, 2026Latest source record: Dec 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
450
Actual
Start
Mar 8, 2007
Primary completion
Mar 3, 2015
Study completion Mar 3, 2015
Sponsor
- Lead sponsor
- Astellas Pharma IncAstellas (ALPMY)
- Sponsor type
- Industry
- Collaborators
- Basilea Pharmaceutica
- First posted
- Dec 19, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to compare the safety and efficacy of isavuconazole versus caspofungin followed by voriconazole in the treatment of candidemia and other invasive Candida infections.
Conditions
- Candidiasis, Invasive
- Candidemia
- Mycoses
Interventions
IsavuconazoleDrug
Administered by intravenous infusion.
CaspofunginDrug
Administered by intravenous infusion.
VoriconazoleDrug
Administered by intravenous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Overall Response of Success at the End of Intravenous Therapy (EOIV) as Determined by the Data Review Committee (DRC) Based on the Assessments of Clinical and Mycological Responses as Well as Alternative Systemic AFT UseTime frame: End of Intravenous Treatment (EOIV) (Days 11-56)
Locations
113 sites in 25 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Somero Research Corporation
Palm Desert, California
University of California Davis Health System
Sacramento, California
University of California at San Francisco
San Francisco, California
Idaho Falls Infectious Diseases PLLC
Idaho Falls, Idaho
Loyola University Hospital
Maywood, Illinois
Springfield Clinic LLP
Springfield, Illinois
Infectious Disease of Indiana
Indianapolis, Indiana
Ochsner Clinic Foundation
New Orleans, Louisiana
University of Maryland School of Medicine
Baltimore, Maryland
UMASS Memorial Medical Center
Worcester, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Mercury Street Medical Group
Butte, Montana
Jersey Shore University Medical Center
Neptune City, New Jersey
New York Presbyterian Hospital
New York, New York
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Regional Infection Diseases Infusion Center Inc.
Lima, Ohio
Temple University Health Sciences
Philadelphia, Pennsylvania
Hospital Britanico de Buenos Aires
Capital Federal, Argentina
Hospital General de Agudos Dr. Carlos G. Durand
Capital Federal, Argentina
Hospital Italiano de Buenos Aires
Ciudad Autonoma, Argentina
Instituto Medico Especializado Alexander Fleming
Ciudad Autonoma, Argentina
Hospital General de Agudos Dr. Cosme Argerich
La Boca, Argentina
Fremantle Hospital
Fremantle, Australia
Mater Adult Hospital
South Brisbane, Australia
Westmead Hospital
Westmead, Australia
Princess Alexandra Hospital
Woolloongabba, Australia
Institut Jules Bordet
Brussels, Belgium
ULB Hôpital Erasme
Brussels, Belgium
Universitair Ziekenhuis Brussel
Brussels, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Universitaire Ziekenhuizen Leuven
Leuven, Belgium
Hospital Felicio Rocho
Belo Horizonte, Brazil
Hospital das Clinicas da Universidade Federal de Minas Gerai
Belo Horizonte, Brazil
Santa Casa de Misericordia de Belo Horizonte
Belo Horizonte, Brazil
Hospital das Clinicas da UFPR
Curitiba, Brazil
Hospital Nossa Senhora das Gracas
Curitiba, Brazil
Hospital Sao Lucas - PUCRS
Porto Alegre, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Brazil
Hospital Universitario Clementino Fraga Filho
Rio de Janeiro, Brazil
Showing 40 of 113 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.